Cormorant Asset Management

Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.

Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.

See All Exits Recent Exits

Phone:

Fax:



Boston,
Massachusetts, United States

Cormorant Asset Management - Investments & Acquisitions

Show Real Data Cormorant Asset Management Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-08-13Orchard TherapeuticsSeries C$150MAgent Capital, ArrowMark Partners, Baillie Gifford & Co., Cowen Group, Deerfield Management, Driehaus Capital Management, Foresite Capital, Ghost Tree Capital Group, Medison Ventures, Perceptive Advisors, RA Capital Management, RTW Investments, Sphera Global Healthcare, Temasek Holdings, and Venrock
2018-06-08Precision BioSciencesSeries B$110MAdage Capital Management, Agent Capital, Alexandria Venture Investments, Amgen Ventures, ArrowMark Partners, Brace Pharma Capital, Cowen Group, DUMAC, F-Prime Capital, Franklin Templeton Investments, Gilead Sciences, Leerink Partners, OCV Partners, Osage University Partners, Pontifax AgTech, RA Capital Management, Ridgeback Capital Management, The Longevity Fund, venBIO, and Vivo Capital
2018-05-15Supira MedicalSeries A$15.5MShifamed, and The Capital Partnership
2018-04-26Innovent BiologicsSeries E$150MAlly Bridge Group, Capital Group Private Markets, Hillhouse Capital Management, Legend Capital, Lilly Asia Ventures, Rock Springs Capital, Taikang Life Insurance Company, and Temasek Holdings
2018-04-25Corvidia TherapeuticsSeries B$60MAndera Partners, Apple Tree Partners, Fresenius Medical Care, HBM Healthcare Investments, MedImmune Ventures, Sofinnova Partners, and Venrock
See all 5 investments